Speaker illustration

Associate Professor Luiz Carlos Passos

Federal University of Bahia, Salvador (Brazil)

Complications after implants of cardiac electronic device in acute heart failure

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Optimized medical therapy at admission vs the moment of discharged in patient acute heart failure

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Acute Heart Failure

Thumbnail

Acute renal failure as a predictor for in-hospital death in acute heart failure patients

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Is acute renal failure associated to worse prognosis after a cardiac device implant?

Event: Heart Failure 2018

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Chronic Heart Failure – Treatment

Thumbnail

Elegibility for sacubitril/valsartan utilization in acute heart failure

Event: Heart Failure 2018

Topic: Treatment

Session: Acute Heart Failure– Treatment

Thumbnail

Multiprofessional team on acute heart failure improves short-term outcomes: results from a cohort

Event: Heart Failure 2018

Topic: Multidisciplinary Interventions

Session: Acute Heart Failure– Treatment

Thumbnail

Is chagas heart disease associated to a higher mortality at one year after cardiac resynchronization therapy implant?

Event: EHRA 2018

Topic: Resynchronization Therapy

Session: CRT

Thumbnail

Are patients with heart failure properly treated at the time of the indication for cardiac device implant?

Event: EHRA 2018

Topic: Chronic Heart Failure – Treatment

Session: CRT

Thumbnail

Clinical outcomes after implanted heart devices (implantable cardioverter defibrilator and cardiac resynchronization): a retrospective cohort in Brazil Northeast region

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Devices (Pacing)

Session: Cardiac Pacing

Thumbnail

Acute heart failure due to chagas heart disease worsening: is it clinically distinct and potentially more critical than other etiologies?

Event: EuroHeartCare 2017

Topic: Heart failure

Session: Heart failure

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb